GB Sciences, Inc. (GBLX)
OTCMKTS: GBLX · Delayed Price · USD
0.0099
+0.0034 (52.31%)
Jul 3, 2024, 12:48 PM EDT - Market closed

GB Sciences Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year
20222021202020192018 2017 - 2002
Net Income
-2,631,569.131.66-4.78-11.64-23.65
Upgrade
Depreciation & Amortization
0.060.070.050.260.62
Upgrade
Share-Based Compensation
0.020.060.440.290
Upgrade
Other Operating Activities
2,631,568-3.652.116.6113.79
Upgrade
Operating Cash Flow
-1.53-1.87-2.19-4.48-9.24
Upgrade
Capital Expenditures
-0.03-0.2-0.29-0.29-10.58
Upgrade
Acquisitions
01.65000
Upgrade
Other Investing Activities
-04.95-0.24-1.05
Upgrade
Investing Cash Flow
-0.031.454.66-0.54-11.63
Upgrade
Common Stock Issued
1.480.141.080.7910.44
Upgrade
Share Repurchases
0000-0.81
Upgrade
Other Financing Activities
-0.05-0.63-2.554.26.27
Upgrade
Financing Cash Flow
1.43-0.5-1.484.9917.52
Upgrade
Net Cash Flow
-0.12-0.910.64-0.03-3.35
Upgrade
Free Cash Flow
-1.56-2.07-2.48-4.77-19.82
Upgrade
Free Cash Flow Margin
----152.98%-573.83%
Upgrade
Free Cash Flow Per Share
-0.00-0.01-0.01-0.02-0.09
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.